Home

DHF

Dengue hemorrhagic fever (DHF) is a severe form of dengue virus infection characterized by fever, vascular fragility, and hemorrhagic manifestations that can progress to dengue shock syndrome if not treated. It typically occurs after a person has been infected with a different dengue virus serotype than a previous infection, due to immune enhancement that increases disease severity. Transmission occurs through bites of Aedes mosquitoes, especially Aedes aegypti and Aedes albopictus, which are common in tropical and subtropical regions.

Signs and symptoms usually begin with high fever, headache, retro-orbital pain, and muscle or joint pains. As

Diagnosis relies on clinical presentation in the appropriate epidemiologic setting, supported by laboratory tests. Early in

Management is supportive and time-sensitive, focusing on careful fluid management to restore intravascular volume while monitoring

Prevention centers on mosquito control and personal protection to reduce transmission. Vaccination with Dengvaxia (CYD-TDV) is

illness
progresses,
patients
may
develop
abdominal
pain,
persistent
vomiting,
mucosal
bleeding,
petechiae,
and
ecchymosis.
In
DHF,
plasma
leakage
can
lead
to
pleural
effusion,
ascites,
and
hemoconcentration,
with
shock
possibly
developing
in
severe
cases
if
leakage
is
extensive
or
untreated.
illness,
RT-PCR
or
NS1
antigen
detection
can
confirm
dengue
infection;
later,
dengue-specific
IgM
and
IgG
antibodies
aid
diagnosis.
Key
laboratory
findings
include
thrombocytopenia
and
leukopenia,
with
hemoconcentration
indicating
plasma
leakage.
for
signs
of
shock
or
fluid
overload.
Severe
DHF
requires
hospitalization
and
often
intensive
care.
NSAIDs
are
generally
avoided
due
to
bleeding
risk,
and
corticosteroids
are
not
routinely
recommended.
approved
in
some
countries
for
individuals
with
prior
dengue
infection
(seropositive),
typically
aged
9–45,
and
is
not
advised
for
seronegative
individuals
due
to
safety
concerns.
Ongoing
research
seeks
safer,
more
effective
vaccines
and
broader
vector-control
strategies.